openPR Logo
Press release

Bronchopulmonary Dysplasia Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approval, NDA Approval, Mechanism of Action, Route of Administration, and Companies by DelveInsight

05-07-2025 05:06 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Bronchopulmonary Dysplasia Clinical Trials

Bronchopulmonary Dysplasia Clinical Trials

(Albany, USA) DelveInsight's, "Bronchopulmonary Dysplasia Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Bronchopulmonary Dysplasia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Bronchopulmonary Dysplasia Research. Learn more about our innovative pipeline today! @ Bronchopulmonary Dysplasia Pipeline Outlook - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Bronchopulmonary Dysplasia Pipeline Report
• In April 2025, Airway Therapeutics, Inc announced results of a Randomized, Double-Blind Parallel-Group, Phase 3 Multicenter Study to Evaluate the Efficacy of Zelpultide Alfa in Preventing Bronchopulmonary Dysplasia (BPD) in High-Risk Preterm Neonates Compared to Standard of Care (SOC)
• In March 2025, Oak Hill Bio Ltd announced results of a Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
• In February 2025, Medipost Co Ltd announced results of a Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
• In September 2024:- EXO Biologics S.A.- Phase I Single Arm, Dose Escalating and Phase II Double Blind, Randomized, Placebo-controlled, Dose Finding Clinical Trial Assessing Safety and Efficacy of Intratracheal Administration of Allogeneic Umbilical Cord Mesenchymal Cells-derived Extracellular Vesicles in Preventing Bronchopulmonary Dysplasia in Extremely Preterm Newborns.
• DelveInsight's Bronchopulmonary Dysplasia pipeline report depicts a robust space with 12+ active players working to develop 12+ pipeline therapies for Bronchopulmonary Dysplasia treatment.
• The leading Bronchopulmonary Dysplasia Companies such as MEDIPOST Co., Ltd., Airway Therapeutics, Oak Hill Bio Ltd, Meridigen Biotech, AyuVis Research, CHIESI Farmaceutici S.p.A., Velvio, Orphanix, Alveolus Bio Inc., Advent Therapeutics, Trimunocor, The Cell Factory BVBA, Windtree Therapeutics, and others.
• Promising Bronchopulmonary Dysplasia Therapies such as Sildenafil, PNEUMOSTEM, OHB-607, and others.

Stay informed about the cutting-edge advancements in Bronchopulmonary Dysplasia Treatments. Download for updates and be a part of the revolution in cancer care @ Bronchopulmonary Dysplasia Clinical Trials Assessment - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Bronchopulmonary Dysplasia Emerging Drugs Profile
• PNEUMOSTEM: MEDIPOST Co., Ltd.
PNEUMOSTEM Registered an allogeneic umbilical cord blood-derived mesenchymal stem cell product, is currently under development for the preventive treatment of Bronchopulmonary Dysplasia (BPD) in premature infants. Currently, Phase 2 clinical trial is ongoing in Korea and PNEUMOSTEM Registered has been Orphan Drug designated by US FDA and EMA. Recently, US FDA granted a Fast Track Designation for PNEUMOSTEM Registered .

• AT-100: Airway Therapeutics
AT-100 is a novel recombinant human protein rhSP-D, an engineered version of an endogenous protein that reduces inflammation and infection in the body while modulating the immune response to break the cycle of injury and inflammation. Airway is focused on advancing AT-100 for the prevention of BPD in very preterm born babies and as a therapeutic for seriously ill COVID-19 patients. AT-100's anti-inflammatory and anti-infective properties also make it a potential treatment for other respiratory diseases such as influenza, respiratory syncytial virus (RSV) and inflammatory diseases outside the lung. The FDA and European Medicines Agency have granted AT-100 Orphan Drug Designation.

Learn more about Bronchopulmonary Dysplasia Drugs opportunities in our groundbreaking Inter Bronchopulmonary Dysplasia Research and development projects @ Bronchopulmonary Dysplasia Unmet Needs - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Bronchopulmonary Dysplasia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Bronchopulmonary Dysplasia Products have been categorized under various Molecule types such as
Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Discover the latest advancements in Bronchopulmonary Dysplasia Treatment by visiting our website. Stay informed about how we're transforming the future of Oncology @ Bronchopulmonary Dysplasia Market Drivers and Barriers, and Future Perspectives - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Bronchopulmonary Dysplasia Pipeline Report
• Coverage- Global
• Bronchopulmonary Dysplasia Companies- MEDIPOST Co., Ltd. (KOSDAQ: 078160), Windtree Therapeutics, Inc. (NASDAQ: WINT), Airway Therapeutics, Oak Hill Bio Ltd, Meridigen Biotech, AyuVis Research, CHIESI Farmaceutici S.p.A., Velvio, Orphanix, Alveolus Bio Inc., Advent Therapeutics, Trimunocor, The Cell Factory BVBA, and others
• Bronchopulmonary Dysplasia Therapies- Sildenafil, PNEUMOSTEM, OHB-607, and others.
• Bronchopulmonary Dysplasia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Bronchopulmonary Dysplasia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Bronchopulmonary Dysplasia Pipeline on our website @ Bronchopulmonary Dysplasia Drugs and Companies - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
• Introduction
• Executive Summary
• Bronchopulmonary Dysplasia: Overview
• Pipeline Therapeutics
• Therapeutic Assessment
• Bronchopulmonary Dysplasia - DelveInsight's Analytical Perspective
• Late Stage Products (Phase III)
• Drug name: Company name
• Drug profiles in the detailed report.....
• Mid Stage Products (Phase II)
• PNEUMOSTEM: MEDIPOST Co., Ltd.
• Drug profiles in the detailed report.....
• Early Stage Products (Phase I)
• AT-100: Airway Therapeutics
• Drug profiles in the detailed report.....
• Preclinical and Discovery Stage Products
• AVR 48: AyuVis Research
• Drug profiles in the detailed report.....
• Inactive Products
• Bronchopulmonary Dysplasia Key Companies
• Bronchopulmonary Dysplasia Key Products
• Bronchopulmonary Dysplasia- Unmet Needs
• Bronchopulmonary Dysplasia- Market Drivers and Barriers
• Bronchopulmonary Dysplasia- Future Perspectives and Conclusion
• Bronchopulmonary Dysplasia Analyst Views
• Bronchopulmonary Dysplasia Key Companies
• Appendix

Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchopulmonary Dysplasia Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approval, NDA Approval, Mechanism of Action, Route of Administration, and Companies by DelveInsight here

News-ID: 4002326 • Views:

More Releases from DelveInsight Business Research

Dystrophic Epidermolysis Bullosa Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, NICE Approvals, Therapies, Medication, NDA Approval, IND, Mechanism of Action, Route of Administration and Companies by DelveInsight
Dystrophic Epidermolysis Bullosa Clinical Trials Analysis 2025: EMA, PDMA, FDA A …
(Albany, USA) "Dystrophic Epidermolysis Bullosa Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Dystrophic Epidermolysis Bullosa Market. Dystrophic Epidermolysis Bullosa pipeline constitutes 15+ key companies continuously working towards developing 15+ Dystrophic Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Dystrophic Epidermolysis Bullosa Pipeline report embraces in-depth commercial and
Cancer Anorexia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Helsinn Healthcare, Artelo Biosciences, NGM Biopharma
Cancer Anorexia Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Forecast https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Axial Spondyloarthritis Market to Expand Significantly by 2034, States DelveInsight Report | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly
Axial Spondyloarthritis Market to Expand Significantly by 2034, States DelveInsi …
DelveInsight's "Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Axial Spondyloarthritis, historical and forecasted epidemiology as well as the Axial Spondyloarthritis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Axial Spondyloarthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axial Spondyloarthritis Market Forecast https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Cystic Fibrosis Market Growth Projections 2024-2034: DelveInsight Analysis | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed
Cystic Fibrosis Market Growth Projections 2024-2034: DelveInsight Analysis | Ins …
DelveInsight's "Cystic Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cystic Fibrosis, historical and forecasted epidemiology as well as the Cystic Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cystic Fibrosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cystic Fibrosis Market Forecast https://www.delveinsight.com/sample-request/cystic-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the

All 5 Releases


More Releases for Market:

India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by
Global Organic Food & Beverage Market | Market Size, Market Share, Market Trends …
The term 'organic' has gained much popularity since the last decade, which refers to the process of how certain foods are produced. Organic food is grown without the use of synthetic chemicals, such as human-made pesticides and fertilizers, and does not contain genetically modified organisms (GMOs). According to the recently published report titled, 'Global Organic Food & Beverage Outlook, 2026', by Bonafide Research the organic foods & beverage industry has
Robotic Cardiology Surgery Market Insights Includes Market Share, Market Researc …
Robotic Cardiology Surgery Market Global demand for cardiac surgery robots in 2025 will explode to $XXX billion. This represents an astonishing XX% growth yearly in terms of annual revenue between 2016 and 2025, and a cumulative market total of $7.50 billion during 2017-2025 owing to the substantial increase of robot-based and computer-assisted cardiological surgery procedures for heart disorders. Global Robotic Cardiology Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy is based
Educational Robots Market, Market Segmentation, Market Report, Market Forecast
Global Educational Robots market valued USD 670 Million in 2017 and is likely to grow more than USD 2339.8 Million by 2025 with a compounded annual growth of 16.92% over the forecast period 2018-2025. The market growth is primarily driven by technological enhancements in the field of robotics and increasing use of robots for educational purposes. However, high initial research and development expenses hamper market growth. The main function of